期刊文献+

米非司酮合用顺铂对卵巢癌耐药细胞株COC1/DDP增殖及凋亡的影响 被引量:3

Effect of mifepristone combine diamminedichloroplatinum on drug fast ovarian cancer cell lines COC1/DDP proliferation and apoptosis
下载PDF
导出
摘要 目的:探讨米非司酮合用顺铂对卵巢癌耐药细胞株COC1/DDP增殖及凋亡率的影响。方法:采用MTT法观察不同浓度的米非司酮合用顺铂对COC1/DDP细胞株增殖活力的影响,采用流式细胞术观察不同浓度的米非司酮合用顺铂对COC1/DDP细胞株凋亡率的影响。结果:对照组和顺铂组比较,米非司酮加顺铂组细胞增殖活力OD值明显下降,细胞凋亡率明显升高,且随着米非司酮浓度的升高变化愈加显著(P<0.05和P<0.01)。结论:米非司酮联合顺铂对COC1/DDP细胞增殖活力均具有显著抑制作用,米非司酮可提高顺铂化疗的敏感性,其增敏作用与促进细胞凋亡有关,且与米非司酮的浓度呈剂量依赖关系。 Objective: To study the effect of mifepristone combine dlamminedichloroplatinum (DDP) on drug fast ovarian cancer eell lines COC1/DDP proliferation and apoptosis. Methods: The effect of various density mlfepristone combine DDP on COC1/DDP cell proliferatlon aetlvlty were observed by MTT method; The effect of various density mifepristone eomblne DDP on apoptosls were observed by FCM method. Results: Compared with control and DDP group, the OD value of cell proliferation aetivlty in mlfepristone eomblne DDP group were decreased obviously, and apoptosis rate were increased, the COC1/DDP eyto- inhibition were changed obviously gradually with increase of rrdfepristone density ( P 〈0. 05 or P 〈0. 01 ) . Conclusion: There are obvious cyto- inhibition on COC1/DDP cell proliferation aetivity by mifepristone eomblne DDP, mifepristone could obviously alleviate the chemotherapy sensitivity of DDP, which were relative to improvement of apoptosis, and the function present the certain relation on the dosage.
作者 邢盈 王立英
出处 《中国妇幼保健》 CAS 北大核心 2008年第20期2856-2858,共3页 Maternal and Child Health Care of China
基金 河北省科技攻关计划项目(编号:06276178)
关键词 米非司酮 顺铂 卵巢癌 细胞凋亡 Mifepristone Diamminedichloroplatinum Ovarian cancer Apoptosis
  • 相关文献

参考文献5

二级参考文献37

  • 1陈润硕.现代实用免疫细胞化学技术[M].上海:上海科学技术出版社,1997.86-95.
  • 2Hoekstra D, van Ijzendoom SCD. Lipid trafficking and sorting: how cholesterol is filling gaps. Curt Opin Cell Biol, 2000,12(4): 496-502.
  • 3Lavie Y, Cao H, Bursten SL, et al. Accumulation of glucosylceramide in multidrug-resistant cancer cells. J Biol Chem, 1996, 271(32): 19530-19536.
  • 4Itoh M, Kitano T, Watanabe M, et al. Possible role of ceramide as an indicator of chemoresistance: decrease of the ceramide content via activation of glucosylceramide synthase and sphingomyelin synthase in chemoresistant leukemia. Clin Cancer Res, 2003,9 (1):415-423.
  • 5Lucci A, Han TY, Liu YY, et al. Muhidrug resistance modulators and doxorubicin synergize to elevate cermnide levels and elicit apoptosis in drug-resistant cancer cells. Cancer, 1999, 86(2): 300-311.
  • 6Litvak DA, Bilchik AJ, Cabot MC. Modulators of ceramide metabolism sensitizes colorectal cancer cells to chemotherapy. A novel treatment strategy. J Gastrointest Surg, 2003,7( 1 ):140-148.
  • 7vLucci A, Han TY, Liu YY, et al. Modification of ceramide metabolism increases cancer cell sensitivity to cytotoxics. Int J Oncol, 1999,15(3): 541-546.
  • 8Lucci A, Armaneo E, Giuliano AE, et al. Ceramide toxicity and metabalism differ in wild-type and multidrug-resistant cancer cells.Int J Oncol, 1999,15(3): 535-540.
  • 9Gruol DJ, Bourgeois S. Expression of the mdr1 P-glycoprotein gene: Amechanism of excape from glucocorticoid-induad apoptosis.Biochem Cell Biol, 1994,72( 11-12):561-571.
  • 10Lcureur V, Fardel O, Guillouzo A. The antiprogestin drug RU486 potentiates doxorubicin cytotoxicity in multidrug resistant cells through inhibition of P-glycoprotein function. FEBS Lett, 1994, 355(2): 157-191.

共引文献12

同被引文献24

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部